Citigroup’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $173K | Sell |
82,537
-131,706
| -61% | -$275K | ﹤0.01% | 3416 |
|
|
2025
Q1 | $365K | Buy |
214,243
+42,377
| +25% | +$72.3K | ﹤0.01% | 3094 |
|
|
2024
Q4 | $868K | Buy |
171,866
+106,249
| +162% | +$537K | ﹤0.01% | 2679 |
|
|
2024
Q3 | $357K | Buy |
65,617
+34,196
| +109% | +$186K | ﹤0.01% | 3204 |
|
|
2024
Q2 | $151K | Buy |
31,421
+20,690
| +193% | +$99.3K | ﹤0.01% | 3301 |
|
|
2024
Q1 | $33.4K | Buy |
10,731
+154
| +1% | +$479 | ﹤0.01% | 4094 |
|
|
2023
Q4 | $30K | Buy |
10,577
+9,262
| +704% | +$26.3K | ﹤0.01% | 4058 |
|
|
2023
Q3 | $3.85K | Sell |
1,315
-18,675
| -93% | -$54.7K | ﹤0.01% | 4048 |
|
|
2023
Q2 | $57.2K | Buy |
19,990
+18,815
| +1,601% | +$53.8K | ﹤0.01% | 3891 |
|
|
2023
Q1 | $3.63K | Sell |
1,175
-2,197
| -65% | -$6.79K | ﹤0.01% | 4306 |
|
|
2022
Q4 | $7.12K | Buy |
3,372
+234
| +7% | +$494 | ﹤0.01% | 4235 |
|
|
2022
Q3 | $10K | Sell |
3,138
-1,049
| -25% | -$3.34K | ﹤0.01% | 4249 |
|
|
2022
Q2 | $13K | Sell |
4,187
-7,672
| -65% | -$23.8K | ﹤0.01% | 4511 |
|
|
2022
Q1 | $84K | Buy |
11,859
+7,793
| +192% | +$55.2K | ﹤0.01% | 3807 |
|
|
2021
Q4 | $29K | Buy |
4,066
+4
| +0.1% | +$29 | ﹤0.01% | 4511 |
|
|
2021
Q3 | $47K | Buy |
+4,062
| New | +$47K | ﹤0.01% | 4019 |
|